Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1962 1
1966 1
1969 2
1970 3
1971 1
1972 2
1973 1
1975 1
1976 1
1977 1
1979 2
1980 5
1981 5
1982 3
1983 4
1984 4
1985 10
1986 7
1987 2
1988 7
1989 4
1990 4
1991 3
1992 3
1993 2
1994 7
1995 7
1996 12
1997 7
1998 10
1999 2
2000 2
2001 12
2002 4
2003 1
2004 7
2005 3
2006 12
2007 11
2008 6
2009 4
2010 15
2011 7
2012 13
2013 18
2014 21
2015 13
2016 18
2017 18
2018 10
2019 13
2020 13
2021 17
2022 19
2023 27
2024 25
2025 24
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

437 results

Results by year

Filters applied: . Clear all
Page 1
A Novel GUCY2C-CD3 T-Cell Engaging Bispecific Construct (PF-07062119) for the Treatment of Gastrointestinal Cancers.
Mathur D, Root AR, Bugaj-Gaweda B, Bisulco S, Tan X, Fang W, Kearney JC, Lucas J, Guffroy M, Golas J, Rohde CM, Stevens C, Kamperschroer C, Kelleher K, Lawrence-Henderson RF, Upeslacis E, Yao J, Narula J, LaVallie ER, Fernandez DR, Buetow BS, Rosfjord E, Bloom L, King LE, Tchistiakova L, Nguyen A, Sapra P. Mathur D, et al. Clin Cancer Res. 2020 May 1;26(9):2188-2202. doi: 10.1158/1078-0432.CCR-19-3275. Epub 2020 Jan 29. Clin Cancer Res. 2020. PMID: 31996389
Rovalpituzumab tesirine, a DLL3-targeted antibody-drug conjugate, in recurrent small-cell lung cancer: a first-in-human, first-in-class, open-label, phase 1 study.
Rudin CM, Pietanza MC, Bauer TM, Ready N, Morgensztern D, Glisson BS, Byers LA, Johnson ML, Burris HA 3rd, Robert F, Han TH, Bheddah S, Theiss N, Watson S, Mathur D, Vennapusa B, Zayed H, Lally S, Strickland DK, Govindan R, Dylla SJ, Peng SL, Spigel DR; SCRX16-001 investigators. Rudin CM, et al. Among authors: mathur d. Lancet Oncol. 2017 Jan;18(1):42-51. doi: 10.1016/S1470-2045(16)30565-4. Epub 2016 Dec 5. Lancet Oncol. 2017. PMID: 27932068 Free PMC article. Clinical Trial.
Delivery of gene editing therapeutics.
Kevadiya BD, Islam F, Deol P, Zaman LA, Mosselhy DA, Ashaduzzaman M, Bajwa N, Routhu NK, Singh PA, Dawre S, Vora LK, Nahid S, Mathur D, Nayan MU, Baldi A, Kothari R, Patel TA, Madan J, Gounani Z, Bariwal J, Hettie KS, Gendelman HE. Kevadiya BD, et al. Among authors: mathur d. Nanomedicine. 2023 Nov;54:102711. doi: 10.1016/j.nano.2023.102711. Epub 2023 Oct 7. Nanomedicine. 2023. PMID: 37813236 Free PMC article. Review.
Anti-Extra Domain B Splice Variant of Fibronectin Antibody-Drug Conjugate Eliminates Tumors with Enhanced Efficacy When Combined with Checkpoint Blockade.
Hooper AT, Marquette K, Chang CB, Golas J, Jain S, Lam MH, Guffroy M, Leal M, Falahatpisheh H, Mathur D, Chen T, Kelleher K, Khandke K, Muszynska E, Loganzo F, Rosfjord E, Lucas J, Kan Z, Subramanyam C, O'Donnell C, Neri D, Gerber HP, May C, Sapra P. Hooper AT, et al. Among authors: mathur d. Mol Cancer Ther. 2022 Sep 6;21(9):1462-1472. doi: 10.1158/1535-7163.MCT-22-0099. Mol Cancer Ther. 2022. PMID: 35793468 Free PMC article.
Kyrle`s disease.
Kalla G, Kachhawa D, Goyal AM, Mathur DR. Kalla G, et al. Among authors: mathur dr. Indian J Dermatol Venereol Leprol. 1995 Jul-Aug;61(4):239-40. Indian J Dermatol Venereol Leprol. 1995. PMID: 20952972 No abstract available.
The tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working Group.
El Bairi K, Haynes HR, Blackley E, Fineberg S, Shear J, Turner S, de Freitas JR, Sur D, Amendola LC, Gharib M, Kallala A, Arun I, Azmoudeh-Ardalan F, Fujimoto L, Sua LF, Liu SW, Lien HC, Kirtani P, Balancin M, El Attar H, Guleria P, Yang W, Shash E, Chen IC, Bautista V, Do Prado Moura JF, Rapoport BL, Castaneda C, Spengler E, Acosta-Haab G, Frahm I, Sanchez J, Castillo M, Bouchmaa N, Md Zin RR, Shui R, Onyuma T, Yang W, Husain Z, Willard-Gallo K, Coosemans A, Perez EA, Provenzano E, Ericsson PG, Richardet E, Mehrotra R, Sarancone S, Ehinger A, Rimm DL, Bartlett JMS, Viale G, Denkert C, Hida AI, Sotiriou C, Loibl S, Hewitt SM, Badve S, Symmans WF, Kim RS, Pruneri G, Goel S, Francis PA, Inurrigarro G, Yamaguchi R, Garcia-Rivello H, Horlings H, Afqir S, Salgado R, Adams S, Kok M, Dieci MV, Michiels S, Demaria S, Loi S; International Immuno-Oncology Biomarker Working Group. El Bairi K, et al. NPJ Breast Cancer. 2021 Dec 1;7(1):150. doi: 10.1038/s41523-021-00346-1. NPJ Breast Cancer. 2021. PMID: 34853355 Free PMC article. Review.
Ear sign.
Agarwal US, Mathur D, Mathur D, Besarwal RK, Agarwal P. Agarwal US, et al. Among authors: mathur d. Indian Dermatol Online J. 2014 Jan;5(1):105-6. doi: 10.4103/2229-5178.126064. Indian Dermatol Online J. 2014. PMID: 24616878 Free PMC article. No abstract available.
A Novel B7-H4xCD3 Bispecific T-cell Engager (PF-07260437) Synergizes with Breast Cancer Standard of Care and Immune Checkpoint Therapies.
Abayasiriwardana K, Wu L, Laklai H, Nocula-Lugowska M, Tchistiakova L, Narula J, Jackson-Fisher A, Golas J, Lam MH, Grinstein V, Kang JW, Kearney JC, Hosselet C, Upeslacis E, Lemon L, Zhang Y, Ji C, Buetow BS, Finkelstein MB, Marshall N, Bisulco S, Rosfjord E, Mathur D, Athanacio J, Thomas A, Trageser A, Fernandez D, Jiang ZK, Ram S, Cabral E, Manzuk L, Maresca K, Giddabasappa A, Lees C, Hooper AT, Sapra P, Chintharlapalli S. Abayasiriwardana K, et al. Among authors: mathur d. Mol Cancer Ther. 2025 Jul 2;24(7):976-992. doi: 10.1158/1535-7163.MCT-24-0379. Mol Cancer Ther. 2025. PMID: 40366350 Free PMC article.
Alzheimer's disease transcriptional landscape in ex vivo human microglia.
Kosoy R, Fullard JF, Bendl J, Kleopoulos SP, Shao Z, Argyriou S, Mathur D, Psychogyiou K, Malakates P, Vicari J, Ma Y, Humphrey J, Brophy E, Raj T, Katsel P, Voloudakis G, Lee D, Bennett DA, Haroutunian V, Hoffman GE, Roussos P. Kosoy R, et al. Among authors: mathur d. Nat Neurosci. 2025 Sep;28(9):1830-1843. doi: 10.1038/s41593-025-02020-2. Epub 2025 Aug 4. Nat Neurosci. 2025. PMID: 40760184
Molecular control of pluripotency.
Boyer LA, Mathur D, Jaenisch R. Boyer LA, et al. Among authors: mathur d. Curr Opin Genet Dev. 2006 Oct;16(5):455-62. doi: 10.1016/j.gde.2006.08.009. Epub 2006 Aug 22. Curr Opin Genet Dev. 2006. PMID: 16920351 Review.
437 results